Prof. Mohammad Bakherad | Organic Chemistry | Best Researcher Award

Prof. Mohammad Bakherad | Organic Chemistry | Best Researcher Award

Prof. Mohammad Bakherad | Organic Chemistry | Researcher at Shahrood University of Technology, Iran

Mohammad Bakherad, born in 1969 in Mashhad, Iran, is a distinguished Professor of Organic Chemistry at Shahrood University of Technology. He earned his B.Sc. in Chemistry from Isfahan University (1992) and completed his M.Sc. (1995) and Ph.D. (2002) at Ferdowsi University of Mashhad under the mentorship of Majid M. Heravi and Mohammad Rahimizadeh. With a prolific research career, he has published over 147 ISI-indexed papers, contributing significantly to organic synthesis, heterocyclic chemistry, catalysis, and green chemistry. His expertise in organometallic reagents and innovative synthetic methodologies has gained international recognition. He has mentored numerous students and led cutting-edge research projects. His commitment to academic excellence and scientific contributions continues to shape the field of organic chemistry in Iran and beyond.

Professional Profile :         

Scopus 

Summary of Suitability for Award:

Dr. Mohammad Bakherad is a highly accomplished researcher in the field of organic chemistry, particularly in catalysis, heterocyclic chemistry, and green synthetic methodologies. His academic journey, from earning a Ph.D. in Organic Chemistry at Ferdowsi University of Mashhad to becoming a full Professor at Shahrood University of Technology, demonstrates his dedication to research and innovation. With over 147 ISI-cited papers, his contributions have significantly advanced the understanding and application of novel catalytic and environmentally friendly synthetic approaches. Dr. Mohammad Bakherad’s outstanding publication record, pioneering research in organic synthesis and catalysis, and commitment to sustainable chemistry make him an exceptional candidate for the “Best Researcher Award.” His work has had a profound impact on the scientific community, shaping the future of organic chemistry. His innovative methodologies, leadership in academia, and dedication to mentorship and collaborative research make him highly deserving of this recognition.

🎓Education:

Mohammad Bakherad pursued his B.Sc. in Chemistry at Isfahan University, Iran, from 1988 to 1992. He then continued his academic journey at Ferdowsi University of Mashhad, where he obtained his M.Sc. in Organic Chemistry (1993–1996) and later earned his Ph.D. in Organic Chemistry (1996–2002). His doctoral research was conducted under the supervision of esteemed professors Majid M. Heravi and Mohammad Rahimizadeh, focusing on advanced organic synthesis and heterocyclic chemistry. His academic background provided him with a strong foundation in organic methodologies, catalysis, and the development of novel heterocyclic compounds. Through rigorous training and research, he developed expertise in the synthesis of organic frameworks, organometallic reagents, and green chemistry applications. His educational journey laid the groundwork for a prolific career in organic synthesis, contributing significantly to the field with numerous publications and advancements in catalytic and environmentally friendly synthetic approaches.

🏢Work Experience:

Dr. Mohammad Bakherad has had an extensive academic career, beginning as an Assistant Professor of Organic Chemistry at Shahrood University of Technology in July 2003. His dedication and contributions to research and teaching led to his promotion to Associate Professor in January 2008. In February 2013, he achieved the rank of Professor, solidifying his position as a leading researcher in organic and heterocyclic chemistry. Throughout his career, he has mentored numerous students, guiding them in advanced research methodologies and fostering innovation in catalysis and organic synthesis. His teaching experience spans undergraduate and postgraduate levels, covering specialized topics such as organometallic chemistry, synthetic methodologies, and green chemistry. Additionally, he has been actively involved in collaborative research projects, contributing to cutting-edge developments in organic chemistry. His expertise has led to significant advancements in sustainable chemical processes and the development of novel heterocyclic frameworks.

🏅Awards: 

Dr. Mohammad Bakherad has received numerous accolades in recognition of his outstanding contributions to organic chemistry. He has been honored for his pioneering work in catalysis, green synthetic methods, and heterocyclic chemistry. His research excellence has been acknowledged through multiple awards from national and international scientific organizations. He has been invited as a keynote speaker at prestigious conferences, highlighting his expertise in organic synthesis and catalytic methodologies. His scholarly achievements include being recognized for his high-impact publications in leading scientific journals. Furthermore, his commitment to mentorship and academic excellence has earned him appreciation from students and colleagues alike. As a distinguished researcher, he has also been part of various scientific committees, contributing to the advancement of chemistry education and research. His contributions continue to shape the field, fostering innovation and inspiring future generations of chemists.

🔬Research Focus:

Dr. Mohammad Bakherad’s research focuses on organic synthesis, particularly in heterocyclic chemistry, catalysis, and green synthetic methodologies. He has made significant contributions to the development of novel heterocyclic compounds and organometallic reagents, which play a crucial role in medicinal and materials chemistry. His work in catalytic processes has led to innovative and environmentally friendly approaches for synthesizing complex organic molecules. He has explored palladium-catalyzed reactions, Sonogashira coupling, and cyclocondensation techniques to design efficient synthetic routes. Additionally, his interest in sustainable chemistry has driven his research on recyclable catalysts and water-based reactions, reducing the environmental impact of chemical synthesis. His extensive studies on heteroannulation reactions have resulted in the creation of novel bioactive molecules with potential pharmaceutical applications. With over 147 ISI-cited papers, his research continues to influence advancements in organic and green chemistry, making a lasting impact on the scientific community.

Publication Top Notes:

Synthesis, QSAR modeling, and molecular docking studies of 1,2,3-triazole-pyrazole hybrids as significant anti-cancer and anti-microbial agents

Synthesis of new hybrid compounds of imidazo[1,2-a]pyrimidine/pyridine based on quinoxaline through palladium-catalyzed coupling reactions and heteroannulation

A comprehensive review: medicinal applications and diverse synthetic strategies of pyrimidine-based compounds leveraging Suzuki and Sonogashira reactions

Synthesis, and molecular docking studies of novel 1,2,3-triazoles-linked pyrazole carboxamides as significant anti-microbial and anti-cancer agents

Copper catalysts supported by dehydroacetic acid chitosan schiff base for CuAAC click reaction in water

Citations: 1

Furo, Pyrano, and Pyrido[2,3-d]Pyrimidines: A Comprehensive Review of Synthesis and Medicinal Applications

Citations: 5

Synthesis of new 1,2,3-triazole-linked pyrimidines by click reaction

Synthesis of new 4,5-disubstituted-6-methyl-2-(methylthio) pyrimidines via C-C coupling reactions

New Hybrid Compounds from Imidazole and 1,2,3-Triazole: Efficient Synthesis of Highly Substituted Imidazoles and Construction of Their Novel Hybrid Compounds by Copper-Catalyzed Click Reaction

Citations: 1

An Efficient Synthesis of New Pyrazole-Linked Oxazoles via Sonogashira Coupling Reaction

Citations: 2

Prof. Dr. Pengwei Zhao | Medicinal Chemistry | Best Researcher Award

Prof. Dr. Pengwei Zhao | Medicinal Chemistry | Best Researcher Award

Prof. Dr. Pengwei Zhao | Medicinal Chemistry | Ph.D., Master’s Supervisor at Inner Mongolia Medical University, School of Basic Medical Sciences, China 

Dr. Pengwei Zhao is a Professor at the School of Basic Medical Sciences, Inner Mongolia Medical University, he serves as a master’s supervisor and holds various academic positions. He is a member of the Jiusan Society and actively contributes to scientific research as a registered reviewer for Medical Science Monitor and Chinese Journal of Tissue Engineering Research. He is also a youth editorial board member of Modern Oncology and a director of the Inner Mongolia Bioengineering Society. His research focuses on tumor immunology and pharmacological mechanisms of Mongolian medicine. Dr. Zhao has led multiple national and regional research projects, including studies on β-defensins, immune resistance, and cancer treatment mechanisms. His contributions to microbiology and oncology are widely recognized, with several impactful publications in international journals.

Professional Profile : 

Orcid

Scopus 

Summary of Suitability for Award:

Dr. Pengwei Zhao, a distinguished Professor at Inner Mongolia Medical University, has made significant contributions to tumor immunology, cancer pharmacology, and Mongolian medicine. His research on β-defensins and their role in immune modulation and cancer therapy has led to groundbreaking findings, particularly in colorectal and triple-negative breast cancer (TNBC). With numerous high-impact publications, including in Pharmacogenomics Journal and World Journal of Gastrointestinal Oncology, his work is recognized globally. His ongoing National Natural Science Foundation of China project further highlights his leadership in cancer research.  Dr. Pengwei Zhao’s extensive research, innovative methodologies, and interdisciplinary approach make him an outstanding candidate for the “Best Researcher Award”. His contributions to immunotherapy, autophagy, and microbiome-related cancer treatments have the potential to shape future oncological therapies. Recognizing him with this award would honor his pioneering discoveries and impact on global cancer research.

🎓Education:

Dr. Pengwei Zhao holds a Ph.D. in Basic Medical Sciences with a specialization in tumor immunology and pharmacology. His doctoral research focused on β-defensin-mediated immune modulation and cancer therapy. He pursued his higher education at Inner Mongolia Medical University, where he developed expertise in molecular biology, pharmacology, and immunology. His early education emphasized microbiology and traditional Mongolian medicine. Dr. Zhao further enhanced his skills through postdoctoral research and collaborations with leading scientists in cancer biology. His education provided a strong foundation in oncological pharmacology, signaling pathways, and immune resistance mechanisms. He has continuously expanded his knowledge through national and international conferences, workshops, and training programs. His academic journey reflects a commitment to translational research, bridging basic science with clinical applications in cancer therapy.

🏢Work Experience:

Dr. Zhao has been a Professor at Inner Mongolia Medical University for several years, where he also serves as a Master’s Supervisor. His professional roles extend beyond teaching, as he holds multiple directorial positions in national and regional scientific societies. He is a reviewer for prestigious journals, including Medical Science Monitor and Chinese Journal of Digestive Diseases. As a youth editorial board member of Modern Oncology, he actively contributes to cancer research. He has successfully led multiple research projects funded by national and regional agencies, focusing on cancer immunology, microbiology, and Mongolian medicine-based therapies. Additionally, Dr. Zhao has conducted collaborative research on β-defensins, autophagy, and immune resistance mechanisms. His expertise in pharmacological pathways and microbial interactions has significantly advanced the understanding of cancer treatment. He has also been invited as a speaker and panelist at various oncology and pharmacology conferences.

🏅Awards: 

Dr. Pengwei Zhao has received multiple prestigious awards and honors in recognition of his contributions to tumor immunology and Mongolian medicine research. He has been honored by the Inner Mongolia Medical University for excellence in research and mentorship. His work on β-defensins and their role in cancer has earned him accolades from Inner Mongolia’s Science and Technology Department. He has also received distinguished reviewer awards from journals such as Medical Science Monitor and Chinese Journal of Tissue Engineering Research. As a key member of the Chinese Society of Ethnomedicine and Pharmacy, he has been acknowledged for his research on the pharmacological mechanisms of traditional Mongolian medicine. His contributions to microbiology and immunology have been recognized by the Inner Mongolia Microbiology Society, and he has been invited as a young committee member of the Chinese Microbiological Society’s Clinical Microbiology Professional Committee.

🔬Research Focus:

Dr. Pengwei Zhao’s research primarily focuses on tumor immunology, cancer pharmacology, and the therapeutic potential of Mongolian medicine. He investigates the molecular mechanisms of β-defensins in cancer, particularly their role in immune regulation and tumor suppression. His work explores how β-defensin-1 peptides modulate PD-1/PD-L1 immune resistance in colorectal cancer. Additionally, he studies Mongolian medicinal formulations like Sendeng-4 and their mechanisms against skin cancer. His research also extends to microbiology, analyzing how bacterial infections, such as those caused by Staphylococcus aureus and Klebsiella pneumoniae, influence lung epithelial immune responses. Dr. Zhao has also contributed significantly to understanding long noncoding RNAs (lncRNAs) and their regulatory impact on autophagy pathways in cancer. His interdisciplinary approach integrates immunology, molecular biology, and ethnopharmacology, providing novel insights into cancer therapy, host-pathogen interactions, and the development of targeted immunotherapies.

Publication Top Notes:

Upregulation of p300 in paclitaxel-resistant TNBC: implications for cell proliferation via the PCK1/AMPK axis

Authors: P. Zhao, Pengwei; J. Cui, Jiaxian; X. Wang, Xiumei

Journal: Pharmacogenomics Journal

Year: 2024

Citations: 2

Human β-defensin-1 affects the mammalian target of rapamycin pathway and autophagy in colon cancer cells through long non-coding RNA TCONS_00014506

Authors: Y. Zhao, Yuxin; Y. Cui, Yan; X. Li, Xinhong; L. Bao, Lili; P. Zhao, Pengwei

Journal: World Journal of Gastrointestinal Oncology

Year: 2024

Citations: 3

Effect of Staphylococcus aureus in pneumonia mouse model on promotion of mBD-3 expression through ERK1/2

Authors: Yongqing Ni, Xiaoduo Bi, Pengwei Zhao

Ligilactobacillus salivarius LZZAY01 accelerated autophagy and apoptosis in colon cancer cells and improved gut microbiota in CAC mice

Authors: Yang W, Li T, An S, Chen R, Zhao Y, Cui J, Zhang M, Lu J, Tian Y, Bao L, Zhao P

Journal: Microbiol Spectrum

Year: 2025

LPS Promoted HPMEC Autophagy by Suppression of the PI3K/Akt/mTOR through Inhibited TIMAP-Promoted Moesin Expression in Sepsis

Authors: Jili Wen, Pengwei Zhao, HuiJuan Ren, JunMin Wu

Journal: Journal of Biological Regulators and Homeostatic Agents

Year: 2023

 

Khalid Khan | Organic Chemistry | Best Researcher Award

Assoc Prof Dr. Khalid Khan | Organic Chemistry | Best Researcher Award

Associate Professor at Islamia College University, Peshawar, Pakistan

Dr. Khalid Khan is an accomplished chemist with extensive expertise in organic chemistry and medicinal research. He obtained his PhD from Huazhong University of Science and Technology in China, focusing on the design and synthesis of novel dendro-calix[4]arenes. Currently, he serves as an Associate Professor at Islamia College University in Peshawar, Pakistan, where he leads various research projects and supervises graduate and undergraduate students. His work has significantly contributed to the field of drug discovery, particularly in computational and medicinal chemistry.

Author Metrics

Scopus Profile

Dr. Khan has published over 25 research articles in reputable journals, showcasing his research impact and contribution to the field of chemistry. His work has garnered numerous citations, reflecting the relevance and influence of his research on both national and international platforms. His publication metrics highlight his active engagement in advancing scientific knowledge, particularly in the areas of antiviral drug development and nanotechnology.

  • Citations: 414 citations across 379 documents
  • Documents: 21 published works
  • h-index: 9

Education

Dr. Khan completed his PhD in Chemistry from Huazhong University of Science and Technology, China (2008-2013), where he conducted groundbreaking research on nonionic amphiphilic dendro-calix[4]arenes. He holds a Master’s degree in Chemistry from the University of Peshawar (2002-2004), where he graduated with first-class honors, and a Bachelor’s degree in Biological Science from Government College Peshawar (2000-2002).

Research Focus

Dr. Khan’s research primarily revolves around organic chemistry, with a special focus on the synthesis and characterization of bioactive compounds. He is particularly interested in the development of antiviral agents and the computational modeling of drug interactions with viral proteins. His innovative research projects often explore the structure-activity relationships of compounds to enhance therapeutic efficacy.

Professional Journey

Beginning his career as a lecturer in 2005, Dr. Khan progressively advanced to the role of Associate Professor in 2020 at Islamia College University. Throughout his tenure, he has significantly contributed to the academic environment by designing curricula, supervising research, and engaging in community service. His professional journey is marked by a commitment to education, research, and the development of future scientists.

Honors & Awards

Dr. Khan has received several prestigious awards, including the Pakistan and Chinese Government Cultural Exchange Scholarship for his doctoral studies. He was recognized as the topper in his Master’s program, reflecting his dedication and excellence in the field of chemistry. His achievements have earned him a respected place among his peers in academia.

Publications Noted & Contributions

Among his numerous publications, key works include research on the design and synthesis of novel dendro-calix[4]arenes, antiviral drug development, and the characterization of compounds with potential therapeutic applications. His contributions have advanced understanding in various areas of organic chemistry and nanotechnology, facilitating further research in these domains.

Homology modeling and molecular docking study of metabotropic glutamate receptor 5 variant F: An attempt to develop drugs for treating CNS diseases

  • Authors: Ahmad, N., Khan, K., Rashid, H.U., Ullah, R., Ali, E.A.
  • Journal: Zeitschrift für Physikalische Chemie
  • Year: 2024
  • Volume: 238, Issue 8, Pages 1551–1577
  • Citations: 1

Direct synthesis, characterization, in vitro and in silico studies of simple chalcones as potential antimicrobial and antileishmanial agents

  • Authors: Ur Rashid, H., Khan, S., Irum, Shah, T., Khan, K.
  • Journal: Royal Society Open Science
  • Year: 2024
  • Volume: 11, Article 240410
  • Citations: 0

Homology modeling and molecular docking study of corticotrophin-releasing hormone: An approach to treat stress-related diseases

  • Authors: Ahmad, N., Khan, K., Khan, S.W., Ullah, R., Ali, E.A.
  • Journal: Open Chemistry
  • Year: 2024
  • Volume: 22, Article 20240069
  • Citations: 0

Biological investigations of Aspergillus ficuum via in vivo, in vitro and in silico analyses

  • Authors: Shah, Z.A., Khan, K., Shah, T., Muhammad, A., Rashid, H.
  • Journal: Scientific Reports
  • Year: 2023
  • Volume: 13, Article 17260
  • Citations: 1

Insights into metabolic and pharmacological profiling of Aspergillus ficuum through bioinformatics and experimental techniques

  • Authors: Shah, Z.A., Khan, K., Rashid, H.U., Jaremko, M., Iqbal, Z.
  • Journal: BMC Microbiology
  • Year: 2022
  • Volume: 22, Article 295
  • Citations: 4

Research Timeline

Dr. Khan’s research trajectory spans over a decade, beginning with his PhD studies from 2008 to 2013, followed by various research projects involving computational analyses and synthesis of organic compounds. His ongoing projects encompass a wide range of studies aimed at understanding and inhibiting viral proteins, particularly related to SARS-CoV-2 and other pathogenic viruses.

Collaborations and Projects

Dr. Khan has collaborated with both national and international researchers on diverse projects, enhancing the scope and impact of his research. These collaborations have resulted in joint publications and a collective effort to address significant challenges in medicinal chemistry and virology. His ability to work across disciplines and institutions underscores his commitment to collaborative scientific inquiry.

Conclusion

Dr. Khalid Khan’s recognition as a Best Researcher reflects his significant contributions to organic chemistry and medicinal research. His publication record and collaborative efforts enhance his impact within the scientific community. By addressing areas for improvement, such as increasing citation metrics and expanding research diversification, Dr. Khan can further strengthen his position as a leader in his field. His commitment to education and research not only benefits his students but also contributes to the broader scientific landscape, making his work essential for advancements in drug discovery and public health.